Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
180,011
-
Share change
-
-47,205
-
Total reported value
-
$7,164,157
-
Put/Call ratio
-
254%
-
Price per share
-
$39.83
-
Number of holders
-
13
-
Value change
-
-$2,162,962
-
Number of buys
-
5
-
Number of sells
-
9
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q1 2020
As of 31 Mar 2020,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
180,011 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, HRT FINANCIAL LLC, BANQUE PICTET & CIE SA, Traynor Capital Management, Inc., Trexquant Investment LP, Capital Analysts, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Cutler Group LP, UBS Group AG, and Ellis Investment Partners, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.